Christopher Davis, PHARMD in St John, KS - Pharmacist

Christopher Davis, PHARMD is a Pharmacist based in St John, Kansas. Christopher Davis is licensed to practice in Kansas (license number 1-103152) and his current practice location is 329a N Us Highway 281, St John, Kansas. He can be reached at his office (for appointments etc.) via phone at (620) 377-5633.

NPI number for Christopher Davis is 1104415512 and his current mailing address is Po Box 247, St John, Kansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1104415512.

Contact Information

	Christopher Davis, PHARMD
	329a N Us Highway 281, St John, KS 67576-8309
	(620) 377-5633
	(620) 377-5656

Healthcare Provider's Profile

Full Name	Christopher Davis
Gender	Male
Speciality	Pharmacist
Location	329a N Us Highway 281, St John, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1104415512
Provider Enumeration Date: 01/12/2021
Last Update Date: 01/12/2021

Medical Identifiers

Medical identifiers for Christopher Davis such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1104415512	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	1-103152 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Christopher Davis is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Christopher Davis, PHARMD Po Box 247, St John, KS 67576-0247 Ph: () -	Christopher Davis, PHARMD 329a N Us Highway 281, St John, KS 67576-8309 Ph: (620) 377-5633

News Archive

New clues about why immune system fails to kill tumors in mice

A pioneering approach to imaging breast cancer in mice has revealed new clues about why the human immune system often fails to attack tumors and keep cancer in check. This observation, by scientists at the University of California, San Francisco (UCSF), may help to reveal new approaches to cancer immunotherapy.

Economic benefit of federally finded clinical trials exceeds $15 billion

A comprehensive review of all phase III clinical trials supported by one Federal agency finds that, estimated conservatively, the economic benefit in the United States from just eight of these trials exceeded $15 billion over the course of 10 years. The study also found that new discoveries from the trials were responsible for an estimated additional 470,000 healthy years of life. The clinical trials were sponsored by the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NINDS).

NYU Langone experts to present at American Academy of Orthopaedic Surgeons annual meeting

Experts from the Department of Orthopaedic Surgery at NYU Langone Medical Center will present their latest research and clinical findings on diseases of the muscle, tendon, bone and joint at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS), February 7-11 in San Francisco, California.

Neural wiring hints at nervous system gene limits

Genetics may play a surprisingly small role in determining the precise wiring of the mammalian nervous system, according to painstaking mapping of every neuron projecting to a small muscle mice use to move their ears.

Majority of trainee GPs willing to use mindfulness to reduce burnout, study shows

Mindfulness could help trainee GPs to build their resilience and reduce burnout, helping to reduce the number of newly qualified GPs leaving the profession, according to University of Warwick researchers.

Christopher Davis, PHARMD - Pharmacist in St John, KS